NCT00325390View on ClinicalTrials.gov

Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation

PHASE3CompletedINTERVENTIONAL

Enrollment

800

Participants

Timeline

Start Date

July 31, 2004

Conditions

Platelet Aggregation InhibitorsNSTEACS

Interventions

DRUG

clopidogrel (SR25990C)

Trial Locations (1)

Unknown

Sanofi-Aventis, Tokyo

Sponsors

Lead Sponsor

Collaborators (1)

Daiichi Pharmaceuticals

All Listed Sponsors

collaborator

Daiichi Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY